FDA approved Alzheimer’s drug over internal objections
FDA gave the drug conditional approval earlier this month, making it the first new Alzheimer’s therapy approved in nearly 20 years.
Today's Liberal News
By David Lim and Lauren Morello
FDA approved Alzheimer’s drug over internal objections
FDA gave the drug conditional approval earlier this month, making it the first new Alzheimer’s therapy approved in nearly 20 years.
FDA approved Alzheimer’s drug over internal objections
FDA gave the drug conditional approval earlier this month, making it the first new Alzheimer’s therapy approved in nearly 20 years.
FDA approved Alzheimer’s drug over internal objections
FDA gave the drug conditional approval earlier this month, making it the first new Alzheimer’s therapy approved in nearly 20 years.